X
Market Data
$57.15+$15.21 (+36.25%)
XENE · Last trade
Prev Close
$41.94
Range (30d)
$53.38 – $62.76
Recent Filings
- 8-K191.8 KBXenon Pharmaceuticals Inc.Mar 13, 4:10 PM ET·0001193125-26-106144
- 8-K648.4 KBXenon Pharmaceuticals Inc.Mar 12, 4:17 PM ET·0001193125-26-104199
- 8-K11.5 MBXenon Pharmaceuticals Inc.Mar 9, 7:36 AM ET·0001193125-26-097577
- 8-K1.1 MBXenon Pharmaceuticals Inc.Feb 27, 4:03 PM ET·0001193125-26-082520
- 10-K16.9 MBXenon Pharmaceuticals Inc.Feb 26, 4:12 PM ET·0001193125-26-076650
- 8-K421.8 KBXenon Pharmaceuticals Inc.Feb 26, 4:03 PM ET·0001193125-26-076530
- 8-K741.4 KBXenon Pharmaceuticals Inc.Dec 1, 4:05 PM ET·0001193125-25-303862
- 10-Q9.1 MBXenon Pharmaceuticals Inc.Nov 3, 4:31 PM ET·0001193125-25-262646
- 8-K438.8 KBXenon Pharmaceuticals Inc.Nov 3, 4:04 PM ET·0001193125-25-262519
- 8-K/A1.4 MBXenon Pharmaceuticals Inc.Oct 17, 4:37 PM ET·0001193125-25-242583
Insiders
10- AULIN SHERRYChief Financial Officer
- AYCARDI-FONSECA ERNESTOChief Medical Officer
- AZAB MOHAMMADDirector
- BIOTECHNOLOGY VALUE FUND L PSee Explanation of Responses
- Biotechnology Value Trading Fund OS LPSee Explanation of Responses
- Bridger GaryEVP, Research & Development
- BVF INC/IL10% Owner
- BVF PARTNERS L P/IL10% Owner
- BVF Partners OS Ltd.See Explanation of Responses
- Cannon GillianDirector
Tickers
Addresses
business
200 - 3650 GILMORE WAY
BURNABY
mailing
200 - 3650 GILMORE WAY
BURNABY